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f the Hong Kong ThoracSummary Malignant mesothelioma (mesothelioma) is rare. We conducted the first
systematic study of the epidemiology of mesothelioma in Hong Kong from 1988 to
May 2002 by reviewing medical records.
Mesothelioma patients were identified from the database of 12 out of 20 hospitals
that would have admitted mesothelioma patients territory-wide. These 12 hospitals
served 73% of the total hospital bed-years of the 20 hospitals.
We identified 67 mesothelioma patients. The estimated annual incidence was one
per million, which was similar to the background incidence of one to two per million
among Caucasians. Occupational history was available in 43 subjects. Three quarters
of mesothelioma patients with available occupational history had occupational
asbestos exposure.
Restricting analysis to 48 patients with accessible medical records and using 67
occupational asbestosis patients for comparison, the epidemiology of mesothelioma
in Hong Kong shares similarities with the literature: mean age of 63 years upon
diagnosis, mean latency of 46 years, median survival of 9.5 months, male
predominance, selective presentation among women, high prevalence among
workers in ships and dockyards, predominantly epithelioid type, lower prevalence
of asbestos bodies, and negative association with pleural plaques.
Asbestos consumption in Hong Kong rose in the 1970s and peaked in early 1980s
and late 1990s. Hong Kong may encounter an epidemic of mesothelioma in the 2010s
if effective occupational asbestos control measures are not in place.
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K.C. Chang et al.76Introduction
Malignant mesothelioma (mesothelioma) arises
from mesothelial cells. The plasticity of mesothe-
lial cells gives rise to three histological types:
epithelioid, sarcomatoid and biphasic. The epithe-
lioid type is the most common, with reported
prevalence of 60–70% in most series.1
Approximately 80% of mesothelioma cases had
past asbestos exposure.2 Wagner presented the first
piece of evidence implicating asbestos in the
pathogenesis of mesothelioma in a study of South
African miners in 1960.3 Other implicated causes of
mesothelioma include simian virus-40 (SV40),4
radiotherapy or thorium dioxide use,5,6 erionite
fibres,7 chronic pleural inflammation,8 and chemi-
cal carcinogens.9
Asbestos refers to a group of mineral fibres that
occur in two forms: serpentine and amphibole.
Serpentine forms are curly and pliable while
amphibole forms are short, straight and stiff.
Chrysotile fibres are the only serpentine forms.
The major amphiboles that have been used
commercially are crocidolite and amosite. Amphi-
boles are more carcinogenic for mesothelioma than
serpentines10 probably by virtue of their greater
biopersistence and higher iron content.11 The latter
can generate reactive oxygen species that cause
mutagenic oxidative species.12
There are four main sources of asbestos expo-
sure: primary occupations of asbestos mining and
processing, secondary occupations that involve the
industrial and commercial use of asbestos, para-
occupational exposure such as family members who
have occupational exposure, and environmental
exposure.
Mesothelioma is usually diagnosed in the fifth to
seventh decades of life, with a mean age range of
60–65 years.13,14 The tumour has a strong male
predominance,13 which can be explained by the
male predominance of asbestos-exposed occupa-
tions.15 Latency varies with different occupational
groups.16 It is typically over 20 years, usually 30–40
years,17,18 and not infrequently 40 years or long-
er.19,20 Prognosis is poor with a median survival
range of 6–12 months reported in different ser-
ies.21–23 The epithelioid type has the best prog-
nosis.24
The background incidence of mesothelioma,
which was one to two per million per year,10,25,26
has increased as a result of industrial and commer-
cial use of asbestos. In industrialized countries with
heavy asbestos usage from 1940s to 1970s, the
annual incidence of mesothelioma in the 1990s was
2 per million in women and 10–30 per million in
men in the 1980s.27 In the 1990s, the averageannual incidence was 22 per million in the UK,28
and 9 per million in the USA,29 with age-adjusted
incidence rates in the USA around 4 per million for
women and 20 per million for men.30 The incidence
in the USA is stable in younger persons but rising in
men aged above 75 years.31 In Europe the incidence
of mesothelioma is also rising from 5000 dying in
1998 to a projected 9000 men dying by the year
2018, with the highest incidence in the cohort of
men born from 1945 to 1950.32 The incidence of
mesothelioma was estimated to peak in the period
between 2010 and 2020.33
Geographic variations in incidence are due to
regional differences in industrial activity. A high
incidence of mesothelioma (20–60 cases per mil-
lion) has been reported in areas with heavy
shipbuilding activity.34,35 High odds ratios in the
occurrence of mesothelioma were found in many
European shipyard cities,36 notably Walcheren
(23.3), Wilhelmshaven (21.5), Plymouth (14.3),
Dresden (16.8) and New Jersey (26.5). Construction
and building maintenance are currently the most
commonly related jobs in the western countries.37
Mesothelioma is rare in Hong Kong. This may be
related to her industrial activity and the absence of
asbestos mining and processing. The statutory
Pneumoconiosis Medical Board that assesses pneu-
moconiosis compensation claims in Hong Kong has
been the major source of local data on mesothe-
lioma. The Board confirmed the diagnosis of only 22
cases of occupational mesothelioma from 1988 to
mid-2002. Assuming an average population of 5
million in Hong Kong from 1988 to 2002, the overall
annual incidence of mesothelioma was only 0.3
cases per million. Underestimation was likely in
view of the rapid industrialization in Hong Kong
before 1980s.
The epidemiology of mesothelioma in Hong Kong
has not been studied systematically. In 2000, the
Hong Kong Thoracic Society set up rare disease
registries to collect information on various uncom-
mon respiratory diseases. Its Working Group on
Mesothelioma initiated this study to describe the
epidemiology of mesothelioma in Hong Kong.Methods
Mesothelioma patients were identified from the
database of 12 out of 20 public hospitals that would
have admitted mesothelioma patients territory-
wide. These 12 hospitals accounted for approxi-
mately 73% of the total hospital bed-years of the 20
hospitals. Private hospitals that treated approxi-
mately 10% of all in-patients were excluded from
this study.
ARTICLE IN PRESS
9
8
7
6
5
4
3
2
1
19
88
19
89
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
N
um
be
r o
f n
ew
 c
a
se
s
Year of diagnosis
3 3 3 3
5 5 5 5
4
6
8 8
7
2
Figure 1 Number of new cases of mesothelioma in Hong
Kong from 1988 to 2002.
Malignant mesothelioma in Hong Kong 77The following data were retrieved from the
medical records: sex, age at diagnosis, ethnicity,
smoking history, alcoholic history, occupational
history, para-occupational exposure, past health,
drug history, family history of asbestosis or malig-
nancy, presenting symptoms and signs, predomi-
nant sites of disease, special investigations,
histological types, and survival status.
Mesothelioma patients were compared with an
external group, which comprised 67 consecutive
cases of asbestosis confirmed by the statutory
Pneumoconiosis Medical Board from 1986 to the
end of 2000. Four subjects with coexisting me-
sothelioma and asbestosis were included in this
case series and excluded from the external group.
The Board has used the following legal definition of
asbestosis as part of its considerations for the
purpose of occupational compensation: fibrosis of
the lungs due to dust of asbestos or dust containing
asbestos, whether or not such disease is accom-
panied by tuberculosis of the lungs, or any other
disease caused by exposure to such dust.38
The w2 test (with or without Yates’ correction)
and the Fisher’s exact test were used for analysis of
categorical data. Continuous data were analysed
either by Mann-Whitney U test or two-sample
student’s t test depending on the distribution of
data. Kaplan-Meier life-table analysis was used to
compare the 3-year survival rates of mesothelioma
patients and asbestosis patients. SPSS version 10
(SPSS Inc, Chicago, Illinois, USA) was used for data
analysis.Results
Sixty-seven mesothelioma patients were identified.
There were 54 men and 13 women. Figure 1 shows
the distribution of new cases of mesothelioma over
the last 2 decades. Assuming an average population
of 5 million from 1988 to 2002, the overall annual
incidence of mesothelioma in Hong Kong was
approximately one per million.
The medical records of 19 patients were not
accessible for review. The analysis of this study was
mainly based on 48 mesothelioma patients with
accessible medical records. Table 1 summarizes
their characteristics. The most common presenting
symptoms were dyspnoea (54.2%), cough (39.6%),
and chest pain (31.3%). Among the 43 patients with
pleural mesothelioma, the left and the right pleura
were affected in 20 patients and 21 patients
respectively, while bilateral involvement was docu-
mented in two patients.
Occupational history was available in 43 me-
sothelioma patients. Thirty-two out of 43 (approxi-mately three quarters) had occupational asbestos
exposure. The mean age at diagnosis of these 32
patients was 66 years (standard deviation, SD 11
years). Of these 32 patients, 22 (68.8%) had worked
in ships or dockyards (as shipbuilding workers, ship
demolition workers, boiler and pipe workers,
mechanics, engineers, welders, porters, or ware-
house keepers); four (12.5%) were employed in the
construction or demolition site; and six (18.8%) had
other jobs (such as electric workers, air-condition-
ing workers, incinerator plant operators, sandblast-
ing workers, metal workers, and machine
operators). Table 2 summarizes the characteristics
of 11 mesothelioma patients who had no history of
occupational asbestos exposure.
Latency (time between onset of asbestos ex-
posure and diagnosis of mesothelioma) and dura-
tion of asbestos exposure were available in 22
patients. All of them had worked in ships or
dockyards. The mean latency was 46 years (SD 11
years) and the median duration of exposure was 18
years (ranged from nearly 0–42 years).
Table 3 shows a comparison between mesothe-
lioma patients and asbestosis patients. Mesothelio-
ma patients were younger upon diagnosis, more
likely to be female and non-smokers, less likely
to present with cough, sputum and shortness
of breath, less likely to have worked in ships
or dockyards, and less likely to have asbestos
bodies and pleural plaques. The association
between mesothelioma and the female gender
became insignificant after controlling for smoking
history. The negative association between me-
sothelioma and pleural plaques remained signifi-
cant after controlling for the presence of pleural
effusion.
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Table 1 Characteristics of 48 mesothelioma patients with accessible medical records.
Characteristics Descriptions
Gender Male 38 (79.2%)
Female 10 (20.8%)
Age Mean 63.2 (SD 15.4)
Ethnicity All Chinese
Smoking status Ever-smokers 28 (58.3%)
Non-smokers 16 (33.3%)
Unknown 4 (8.3%)
Occupational history With occupational asbestos exposure 32 (66.7%)
No occupational asbestos exposure 11 (22.9%)
Unknown 5 (10.4%)
Clinical presentation Incidental finding 7 (14.6%)
Cough 19 (39.6%)
Cough with sputum 11 (22.9%)
Blood-stained sputum 2 (4.2%)
Dyspnoea 26 (54.2%)
Chest pain 15 (31.3%)
Weight loss 7 (14.6%)
Abdominal symptoms 6 (12.5%)
Investigation other than chest radiographs Tissue (as opposed to cytological) examination 46 (95.8%)
Immunohistochemical staining 39 (81.3%)
Computerized tomography of thorax 26 (54.2%)
Open exploration 24 (50.0%)
Electron microscopy 11 (22.9%)
Site of disease Pleural involvement 43 (89.6%)
Pleura only 35 (72.9%)
Pleura+peritoneum 4 (8.3%)
Pleura+pericardium 3 (6.3%)
Pleura+peritoneum+pericardium 1 (2.1%)
Peritoneum only 5 (10.4%)
Histological types Epithelioid (including 1 with deciduoid features) 22 (45.8%)
Sarcomatoid 4 (8.3%)
Biphasic 10 (20.8%)
Unspecified 12 (25%)
Asbestos bodies Present 6 (12.5%)
Sputum 2
Post-mortem lung tissue 3
Pleura biopsy 1
SD: standard deviation.
34 had computerized tomography of thorax or open exploration.
K.C. Chang et al.78The survival status of 14 mesothelioma patients
could not be ascertained. By the end of 3 years
after diagnosis, 31 out of 48 mesothelioma patients
(64.6%) and 22 out of 67 asbestosis patients (32.8%)
had died. Kaplan-Meier life-table analysis showed a
significantly worse survival for mesothelioma pa-
tients (log rank w2 ¼ 32.6, Po0:0001). The median
survival of mesothelioma patients was 9.5 months
(95% confidence interval 6.3–12.7 months).DiscussionThis is the first systematic study of the epidemiol-
ogy of mesothelioma in Hong Kong. Participating
hospitals accounted for nearly three-quarters of
the total hospital bed-years served by all hospitals
included in the survey. Although its validity may be
limited by the retrospective design and missing
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Table 3 Mesothelioma patients versus occupational asbestosis patients.
Mesothelioma
patients (N ¼ 48)
Occupational
asbestosis
patients (N ¼ 67)
Odds ratio (95% CI) P value
Mean age at diagnosis, years 63.1 (SD 15.4) 69.6 (SD 9.0) 0.011
Female 10 (20.8%) 1 (1.5%) 17.4 (2.1–141.0) 0.001
Non-smokersy 16 (36.4%) 3 (4.7%) 11.6 (3.1–43.1) o0.001z
Median cigarette pack-years (range)y 10.0 (0–100) 30.0 (0–120) 0.002
Occupation related to ships/dockyardsz 22 (51.2%) 47 (70.1%) 0.45 (0.20–0.99) 0.044
Asbestos bodies identified 6 (12.5%) 19 (28.4%) 0.36 (0.13–0.99) 0.042
With pleural plaques 9 (18.8%) 53 (79.1%) 0.06 (0.02–0.16) o0.001
Asymptomatic presentation 7 (14.6%) 7 (10.4%) 1.46 (0.48–4.49) NSz
Cough upon presentation 19 (39.6%) 49 (73.1%) 0.24 (0.11–0.53) o0.001
Cough with sputum upon presentation 11 (22.9%) 40 (59.7%) 0.20 (0.09–0.46) o0.001
Haemoptysis upon presentation 2 (4.2%) 6 (9.0%) 0.44 (0.09–2.29) NS
Chest pain upon presentation 15 (31.3%) 23 (34.3%) 0.87 (0.39–1.92) NS
Dyspnoea upon presentation 26 (54.2%) 51 (76.1%) 0.37 (0.17–0.82) 0.014
Weight loss upon presentation 7 (14.6%) 3 (4.5%) 3.64 (0.89–14.89) NS
SD: standard deviation; CI: confidence interval; NS: non-significant with P value40.05.
Fisher’s exact test.
yData missing in four mesothelioma patients (8.3%) and three asbestosis patients (4.5%).
zWith Yates’ correction.
yData missing in 10 mesothelioma patients (20.8%) and six asbestosis patients (9.0%).
zData missing in five mesothelioma patients (10.4%).
K.C. Chang et al.80data, our study has yielded useful information on
the epidemiology of mesothelioma in Asia.
Approximately three quarters of our mesothelioma
patients with available occupational history had
occupational asbestos exposure. This finding is con-
sistent with the fact that around 80% of mesothelio-
ma patients had past asbestos exposure,2 and
supportive of a definite link between occupational
asbestos exposure and mesothelioma. We described
11 non-occupational mesothelioma patients who had
no obvious occupational asbestos exposure. Their
diseases might be related to environmental or para-
occupational exposure to asbestos,39–41 or other
implicated causes of mesothelioma.4–9
The epidemiology of mesothelioma in Hong Kong is
similar to the literature. Our mesothelioma patients
were predominantly men (approximately 80%).
Nearly 70% of mesothelioma patients with past
occupational asbestos exposure were employed in
ships and dockyards. The mean age at diagnosis of 63
years, the mean latency of 46 years, the median
survival of 9.5 months and the poor 3-year survival
were consistent with the literature. The relatively
long latency might be related to a generally lower
cumulative level of asbestos exposure, as compared
to some western countries with asbestos mining and
processing. The most common histological type of
mesothelioma in our study was the epithelioid type,which constituted around 60% of patients with
known histological types. We noted that asbestos
bodies were significantly less likely to be found
among mesothelioma patients than asbestosis pa-
tients (see Table 3). The prevalence of asbestos
bodies has been shown to relate positively with
cumulative exposure, duration and intensity of
asbestos exposure.42 This finding is also consistent
with the lower dependence on cumulative asbestos
exposure in the development of mesothelioma than
that of asbestosis.43,44
There are two interesting findings in this study.
First, we found a significant association between
mesothelioma and the female gender, which
became insignificant after controlling for smoking
history. A cohort study in Germany also showed that
gender was unlikely to be a risk factor for
mesothelioma.45 Male predominance among smo-
kers and carcinogenic interactions between asbes-
tos and tobacco might have resulted in selective
presentation of women by exerting a survival
disadvantage on men. Second, we found a negative
association between mesothelioma and pleural
plaques. If this association is true, it implies
plaques reduce the risk of mesothelioma. Most of
the available evidence indicates that plaques do
not increase cancer risk11 but a protective effect
has never been proven. It has been postulated that
ARTICLE IN PRESS
Malignant mesothelioma in Hong Kong 81the occurrence of a predominant lymphocytic
alveolitis in some asbestos-exposed workers pro-
motes the development of pleural plaques and
reduces the risk of mesothelioma.46–48 It may be
argued that the negative association is a false
finding caused by the technical difficulty of
detecting pleural plaques in the presence of pleural
effusion among mesothelioma patients. Nonethe-
less, the negative association in our study remained
significant after controlling for the presence of
pleural effusion.
Data from the USA showed that increase in the
incidence of mesothelioma paralleled the use of
asbestos with a lag of 25 to 40 years.30,31 Thus we
may predict the trend of mesothelioma in Hong
Kong by examining the trend of asbestos consump-
tion in the last few decades. The annual consump-
tion of asbestos in Hong Kong has increased
markedly since 1970s. The average annual con-
sumption of crude asbestos (import minus export
and re-export) grew from approximately 100,000 kg
in 1970 to approximately 1,090,000 kg in 1978
(unpublished data from the Department of Census
and Statistics). Although exactly matched data
were not available for the next 2 decades, a high
level of asbestos consumption in Hong Kong was
evident from the annual consumption of asbestos
cement articles in the 1980s and 1990s (see Fig. 2).
Annual consumption peaked around 11,500,000 kg
in the early 1980s, declined for a decade, and then
surged up again in early 1990s to reach around
7,500,000 kg in late 1990s. The decline in the 1980s
might be explained by the closure of major dock-
yards such as the Taikoo Dockyard and the
Whampao Dockyard in the late 1970s, while the
rise in the early 1990s might reflect an increase in
asbestos consumption in the construction industry.
A shift in the contribution of work from shipyards to
the construction industry has also been observed in
the United Kingdom.49 The decline in asbestos12 000 000
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Figure 2 Annual consumption of asbestos cement
articles (kg) in Hong Kong 1980–2003.consumption in the late 1990s coincided with the
prohibition of sale and import of crocidolite and
amosite under the Air Pollution Control Ordinance
enacted in May 1996, and the restriction of
asbestos-related work to registered asbestos pro-
fessionals in 1997. However, the decline might also
be partly related to the economic downturn in the
late 1990s. Hong Kong may have encountered a
small epidemic of mesothelioma that followed the
increase in asbestos consumption in the 1970s and
early 1980s. If effective occupational asbestos
control measures are not in place, an epidemic of
mesothelioma that parallels the surge of asbestos
consumption in the 1990s may occur in the 2010s.
In summary, this study showed that the overall
incidence of mesothelioma in Hong Kong from 1988
to 2002 was at least one case per million per year.
The epidemiology of malignant mesothelioma in
Hong Kong is similar to the literature. We have also
examined the trend of local asbestos consumption
in the last few decades and predicted the trend of
mesothelioma in Hong Kong.
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